propidium has been researched along with Kahler Disease in 16 studies
Propidium: Quaternary ammonium analog of ethidium; an intercalating dye with a specific affinity to certain forms of DNA and, used as diiodide, to separate them in density gradients; also forms fluorescent complexes with cholinesterase which it inhibits.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Histone deacetylase inhibitors such as valproic acid (VPA) are promising drugs for cancer therapy since they have been reported to have antiproliferative effects and to induce differentiation in carcinoma and leukemic cells." | 7.74 | Valproic acid induces non-apoptotic cell death mechanisms in multiple myeloma cell lines. ( Aouali, N; Berchem, G; Bosseler, M; Brons, NH; Leners, B; Palissot, V; Schwartz, C; Wack, S, 2007) |
| "The aim of this study was a contemporaneous measurement of plasma cells proliferative and apoptotic activity in patients examined at the time of multiple myeloma (MM) diagnosis before initiation of chemotherapy, focussed on the following aspects: determination of prognostic significance of plasma cell propidium iodide (PC-PI) and annexin-V FITC (PC-AI) indices; optimal cut off of PC-PI and PC-AI with regard to overall survival; calculation of summary kinetic index of plasma cells (PC-PI/AI ratio) for evaluation of its prognostic importance; determination of an index (out of PC-PI, PC-AI and PC-PI/AI) showing the closest relation to prognosis of multiple myeloma." | 7.73 | Prognostic significance of plasma cell propidium iodide and annexin-V indices and their mutual ratio in multiple myeloma. ( Bacovsky, J; Dusek, L; Minarik, J; Ordeltova, M; Scudla, V; Zemanova, M, 2006) |
| "In a group of 117 patients with multiple myeloma (MM) examined at the time of diagnosis, i." | 5.33 | Evaluation of plasma cell propidium-iodide and annexin-V indices: their relation to prognosis in multiple myeloma. ( Bacovský, J; Minarík, J; Ordeltová, M; Scudla, V; Zemanová, M, 2005) |
| "Bruceantin treatment (2." | 5.32 | Multiple myeloma regression mediated by bruceantin. ( Christov, K; Cuendet, M; Deng, Y; Hedayat, S; Helson, L; Lantvit, DD; McChesney, JD; Pezzuto, JM, 2004) |
| " The purine analogue 8-aminoadenosine (8-NH(2)-Ado) is known to be a transcription inhibitor that has proved very effective in multiple myeloma cell lines and primary indolent leukemia cells." | 3.77 | 8-Aminoadenosine enhances radiation-induced cell death in human lung carcinoma A549 cells. ( Eitaki, M; Inanami, O; Matsuda, A; Meike, S; Yamamori, T; Yasui, H, 2011) |
| " Histone deacetylase inhibitors such as valproic acid (VPA) are promising drugs for cancer therapy since they have been reported to have antiproliferative effects and to induce differentiation in carcinoma and leukemic cells." | 3.74 | Valproic acid induces non-apoptotic cell death mechanisms in multiple myeloma cell lines. ( Aouali, N; Berchem, G; Bosseler, M; Brons, NH; Leners, B; Palissot, V; Schwartz, C; Wack, S, 2007) |
| "The aim of this study was a contemporaneous measurement of plasma cells proliferative and apoptotic activity in patients examined at the time of multiple myeloma (MM) diagnosis before initiation of chemotherapy, focussed on the following aspects: determination of prognostic significance of plasma cell propidium iodide (PC-PI) and annexin-V FITC (PC-AI) indices; optimal cut off of PC-PI and PC-AI with regard to overall survival; calculation of summary kinetic index of plasma cells (PC-PI/AI ratio) for evaluation of its prognostic importance; determination of an index (out of PC-PI, PC-AI and PC-PI/AI) showing the closest relation to prognosis of multiple myeloma." | 3.73 | Prognostic significance of plasma cell propidium iodide and annexin-V indices and their mutual ratio in multiple myeloma. ( Bacovsky, J; Dusek, L; Minarik, J; Ordeltova, M; Scudla, V; Zemanova, M, 2006) |
| "Bone marrow cells of 82 patients with multiple myeloma were subjected to flow cytometric analysis of DNA and cytoplasmic immunoglobulin (CIg) content using propidium iodide and direct immunofluorescence assays." | 3.67 | Cytoplasmic immunoglobulin content in multiple myeloma. ( Alexanian, R; Barlogie, B; Pershouse, M; Smallwood, L; Smith, L, 1985) |
| "In a group of 117 patients with multiple myeloma (MM) examined at the time of diagnosis, i." | 1.33 | Evaluation of plasma cell propidium-iodide and annexin-V indices: their relation to prognosis in multiple myeloma. ( Bacovský, J; Minarík, J; Ordeltová, M; Scudla, V; Zemanová, M, 2005) |
| "Bruceantin treatment (2." | 1.32 | Multiple myeloma regression mediated by bruceantin. ( Christov, K; Cuendet, M; Deng, Y; Hedayat, S; Helson, L; Lantvit, DD; McChesney, JD; Pezzuto, JM, 2004) |
| "Previous studies have suggested that multiple myeloma (MM) cells express estrogen receptors (ER)." | 1.30 | Anti-estrogens induce apoptosis of multiple myeloma cells. ( Anderson, KC; Chauhan, D; Ogata, A; Teoh, G; Treon, SP; Urashima, M; Webb, IJ, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (12.50) | 18.7374 |
| 1990's | 4 (25.00) | 18.2507 |
| 2000's | 8 (50.00) | 29.6817 |
| 2010's | 2 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schmeel, FC | 1 |
| Schmeel, LC | 1 |
| Kim, Y | 1 |
| Schmidt-Wolf, IG | 1 |
| Meike, S | 1 |
| Yamamori, T | 1 |
| Yasui, H | 1 |
| Eitaki, M | 1 |
| Matsuda, A | 1 |
| Inanami, O | 1 |
| Scudla, V | 3 |
| Ordeltova, M | 3 |
| Bacovsky, J | 3 |
| Vytrasova, M | 1 |
| Sumna, E | 1 |
| Martinek, A | 1 |
| Horak, P | 1 |
| Cuendet, M | 1 |
| Christov, K | 1 |
| Lantvit, DD | 1 |
| Deng, Y | 1 |
| Hedayat, S | 1 |
| Helson, L | 1 |
| McChesney, JD | 1 |
| Pezzuto, JM | 1 |
| Fandy, TE | 1 |
| Shankar, S | 1 |
| Ross, DD | 1 |
| Sausville, E | 1 |
| Srivastava, RK | 1 |
| Minarík, J | 2 |
| Zemanová, M | 2 |
| Dusek, L | 1 |
| Schwartz, C | 1 |
| Palissot, V | 1 |
| Aouali, N | 1 |
| Wack, S | 1 |
| Brons, NH | 1 |
| Leners, B | 1 |
| Bosseler, M | 1 |
| Berchem, G | 1 |
| Baumal, R | 1 |
| Musclow, E | 1 |
| Farkas-Himsley, H | 1 |
| Marks, A | 1 |
| Orfäo, A | 1 |
| García-Sanz, R | 1 |
| López-Berges, MC | 1 |
| Belén Vidriales, M | 1 |
| González, M | 1 |
| Caballero, MD | 1 |
| San Miguel, JF | 1 |
| Djuzenova, CS | 1 |
| Zimmermann, U | 2 |
| Frank, H | 1 |
| Sukhorukov, VL | 2 |
| Richter, E | 1 |
| Fuhr, G | 1 |
| Treon, SP | 1 |
| Teoh, G | 1 |
| Urashima, M | 1 |
| Ogata, A | 1 |
| Chauhan, D | 1 |
| Webb, IJ | 1 |
| Anderson, KC | 1 |
| Fosså, A | 1 |
| Brandhorst, D | 1 |
| Myklebust, JH | 1 |
| Seeber, S | 1 |
| Nowrousian, MR | 1 |
| Müller, KJ | 1 |
| Hradcová, M | 1 |
| Marinov, I | 1 |
| Novák, JT | 1 |
| Nemcová, J | 1 |
| Stöckbauer, P | 1 |
| Barlogie, B | 1 |
| Alexanian, R | 1 |
| Pershouse, M | 1 |
| Smallwood, L | 1 |
| Smith, L | 1 |
16 other studies available for propidium and Kahler Disease
| Article | Year |
|---|---|
Piceatannol exhibits selective toxicity to multiple myeloma cells and influences the Wnt/ beta-catenin pathway.
Topics: Animals; Apoptosis; beta Catenin; Cell Line; Cell Line, Tumor; Cell Proliferation; Cell Survival; Fi | 2014 |
8-Aminoadenosine enhances radiation-induced cell death in human lung carcinoma A549 cells.
Topics: Adenocarcinoma; Adenosine; Adenosine Triphosphate; Apoptosis; Caspase Inhibitors; Cell Death; Cell L | 2011 |
A contribution to examination of propidium iodide and annexin V plasma cells indices in multiple myeloma.
Topics: Annexin A5; Apoptosis; Cell Division; Coloring Agents; Humans; Monoclonal Gammopathy of Undetermined | 2003 |
Multiple myeloma regression mediated by bruceantin.
Topics: Animals; Apoptosis; BH3 Interacting Domain Death Agonist Protein; Carbocyanines; Carrier Proteins; C | 2004 |
Interactive effects of HDAC inhibitors and TRAIL on apoptosis are associated with changes in mitochondrial functions and expressions of cell cycle regulatory genes in multiple myeloma.
Topics: Amino Acid Chloromethyl Ketones; Annexin A5; Apoptosis; Apoptosis Regulatory Proteins; Calpain; Casp | 2005 |
Evaluation of plasma cell propidium-iodide and annexin-V indices: their relation to prognosis in multiple myeloma.
Topics: Adult; Aged; Aged, 80 and over; Annexin A5; Apoptosis; Cell Proliferation; Female; Humans; Male; Mid | 2005 |
Prognostic significance of plasma cell propidium iodide and annexin-V indices and their mutual ratio in multiple myeloma.
Topics: Adult; Aged; Aged, 80 and over; Annexin A5; Apoptosis; Cell Proliferation; Female; Humans; Male; Mid | 2006 |
Valproic acid induces non-apoptotic cell death mechanisms in multiple myeloma cell lines.
Topics: Apoptosis; Cadaverine; Carcinoma; Caspases; Cell Cycle; Cell Death; Cell Line, Tumor; Cell Survival; | 2007 |
Variants of an interspecies hybridoma with altered tumorigenicity and protective ability against mouse myeloma tumors.
Topics: Animals; Bacteriocins; Cell Line; Cell Membrane; Flow Cytometry; Hybridomas; Mice; Mice, Inbred BALB | 1982 |
A new method for the analysis of plasma cell DNA content in multiple myeloma samples using a CD38/propidium iodide double staining technique.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Biomarkers, Tumor; Bone Marrow; Cell Cycle; DNA, Ne | 1994 |
Effect of medium conductivity and composition on the uptake of propidium iodide into electropermeabilized myeloma cells.
Topics: Animals; Cell Line; Cell Membrane; Culture Media; Electric Conductivity; Electroporation; Kinetics; | 1996 |
Anti-estrogens induce apoptosis of multiple myeloma cells.
Topics: Apoptosis; Breast Neoplasms; Cell Division; Cell Survival; Coloring Agents; Estradiol; Estrogen Anta | 1998 |
Relation between S-phase fraction of myeloma cells and anemia in patients with multiple myeloma.
Topics: ADP-ribosyl Cyclase; ADP-ribosyl Cyclase 1; Anemia; Antigens, CD; Antigens, Differentiation; Cell Cy | 1999 |
Reversible electropermeabilization of mammalian cells by high-intensity, ultra-short pulses of submicrosecond duration.
Topics: Animals; Cell Membrane Permeability; Electric Conductivity; Electric Stimulation; Electroporation; F | 2001 |
Monoclonal antibody to human chronic myeloid leukemia cell line MOLM-7 specifically reacts with an antigen of apoptotic cells.
Topics: Animals; Antibodies, Monoclonal; Antigens, Neoplasm; Antineoplastic Agents, Phytogenic; Apoptosis; C | 2002 |
Cytoplasmic immunoglobulin content in multiple myeloma.
Topics: Bone Marrow Cells; Cytoplasm; DNA; Flow Cytometry; Fluorescent Antibody Technique; Humans; Immunoele | 1985 |